Please do not leave this page until complete. This can take a few moments.
Walgreens Boots Alliance Inc., parent company to Walgreens, announced Tuesday it will follow up on its August purchase of a controlling stake in CareCentrix, by purchasing the remaining shares of the Hartford-based healthcare technology company.
Walgreens Boots, which is headquartered in Illinois, announced in early September it had invested $300 million for a 55% stake in CareCentrix, a company that had been one of the fastest growing in Hartford over the past decade.
Headquartered in Illinois, Walgreens Boots has sealed an agreement to buy out the remaining 45% stake for approximately $392 million.
Founded in 1996, CareCentrix uses advanced analytics technology to coordinate at-home care for about 19 million patients, working with health insurers, health systems and a network of companies that provide in-home nursing, social work and other services.
CareCentrix CEO John Driscoll, in a recent interview, said the August purchase of a majority stake by Walgreens Boots would allow his company to add prescription management to the home-care services it manages.
Walgreens Boots announced it anticipated closing on the remainder of the CareCentrix by March 2023.
“We continue to see strong results and potential for growth from our partnership with CareCentrix,” said Roz Brewer, CEO of Walgreens Boot Alliance. “Our full acquisition further accelerates our transformation to become a consumer-centric healthcare company, leveraging innovative platforms that extend our capabilities into fast-growing segments of healthcare.”
CareCentrix reported revenue of $1.5 billion in fiscal 2021.
The company will continue as a distinct business and brand within Walgreens following the full acquisition. Driscoll will stay on, assuming the role of executive vice president and president, U.S. Healthcare at Walgreens Boots Alliance, later this month, according to the release.
In 2012, CareCentrix became the fifth company to participate in former Gov. Dannel P. Malloy’s “First Five” program, a somewhat controversial job-creation initiative administered by the Department of Economic and Community Development.
CareCentrix received $24 million in grants and moved its headquarters from East Hartford to Hartford. In exchange, the company was to keep its headquarters in Hartford until 2023, rebuffing relocation offers from lower-cost states, including Kansas and Florida. CareCentrix also pledged to retain 213 jobs and create another 290 by the end of 2017.
CareCentrix created and retained 535 jobs, exceeding its target by 32 jobs, as of Sept. 30, 2017, according to DECD.
In September, CareCentrix tallied 1,877 employees nationally, 346 of whom operate in Connecticut. The company has offices in Hartford and Stamford, as well as in Missouri and Florida.
CareCentrix currently leases 73,941 square feet in the Stilts Building, at 20 Church St. in downtown Hartford.
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments